Dr. Yoshihiro Itabashi, JapanMini-Oral
Effects and adverse events of hypoxia-inducible factor-prolyl hydroxylase inhibitors administration to kidney transplant recipients at a single center in Japan
Dr. Satish Vaarman Jeyabalan, SingaporeMini-Oral
Impact of de novo or worsening of pre-existing valvular heart disease in patients referred to the kidney transplant waitlist – a single centre retrospective cohort study
Dr. Sana Shadab, IndiaMini-Oral
To study the long-term impact of hepatitis C treatment in terms of viral load and liver fibrosis among the renal allograft recipients
Mr. Fayeq Jeelani Syed, United StatesMini-Oral
Potential of 250 New Nautical Mile Concentric Circle Allocation System for Improving the Donor/Recipient HLA Matching
Dr. Islam Madadov, KazakhstanMini-Oral
Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population
Mr. Jainmin Wu, NetherlandsMini-Oral
Polarized HLA class I expression on renal tubules hinders the detection of donor-specific urinary extracellular vesicles